Brief: Biosynex Announces Final Results Of Public Offer On Theradiag Shares
Feb 1 (Reuters) - Biosynex SA ALBIO.PA :
* ANNOUNCEMENT OF THE FINAL RESULTS OF THE BIOSYNEX OPA ON
THERADIAG SHARES
* WILL RETAIN 9,382,354 SHARES, REPRESENTING 71.52% OF THE
CAPTAL
AND 71.22% OF VOTING RIGHTS
Source text for Eikon: ID:
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals